Drugs for Alzheimer's disease
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
Pleiotropic effects of pitavastatin
Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers
Pulse pressure amplification in relation to body fatness
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy
Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application
Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects
Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations
Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients
Influence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteers
Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers
Association between Bcl I polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone
A cross sectional survey of the views of newly registered pharmacists in Great Britain on their potential prescribing role: a cautious approach
Translation Section